Results 41 to 50 of about 877,857 (301)

Risk factors associated with mortality in patients hospitalized for coronavirus disease 2019 in Rio de Janeiro, Brazil

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2021
INTRODUCTION: Understanding the mortality-associated risk factors of coronavirus disease 2019 will impact clinical decisions. METHODS: This retrospective longitudinal study included patients hospitalized for coronavirus disease in Rio de Janeiro, Brazil.
Julio César Delgado Correal   +8 more
doaj   +1 more source

Survival Analysis I: The Kaplan-Meier Method [PDF]

open access: yesNephron Clinical Practice, 2011
The Kaplan-Meier (KM) method is used to analyze ‘time-to-event’ data. The outcome in KM analysis often includes all-cause mortality, but could also include other outcomes such as the occurrence of a cardiovascular event. The purpose of this article is to explain the basic concepts of the KM method, to provide some guidance regarding the presentation of
Stel, V.S.   +4 more
openaire   +3 more sources

Kaplan-Meier analysis of overall survival.

open access: yes, 2021
Kaplan-Meier analysis of overall survival.
Kanokphorn Thonglert (11473288)   +3 more
core   +1 more source

The survivability of dialectical behaviour therapy programmes: a mixed methods analysis of barriers and facilitators to implementation within UK healthcare settings

open access: yesBMC Psychiatry, 2018
Background Dialectical Behaviour Therapy (DBT) is an evidence-based intervention that has been included in the National Institute of Health and Care Excellence guidelines as a recommended treatment for Borderline Personality Disorder in the UK.
Joanne C. King   +3 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann   +8 more
wiley   +1 more source

LocalControl: An R Package for Comparative Safety and Effectiveness Research

open access: yesJournal of Statistical Software, 2020
The LocalControl R package implements novel approaches to address biases and confounding when comparing treatments or exposures in observational studies of outcomes.
Nicolas R. Lauve   +4 more
doaj   +1 more source

Kaplan-Meier Survival Estimates.

open access: yes, 2016
Kaplan-Meier Survival Estimates.
Folefac D. Atem (3597125)   +4 more
core   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman   +9 more
wiley   +1 more source

Kaplan-Meier curves.

open access: yes, 2019
Kaplan-Meier curves for overall survival of all datasets.
Jean-Pierre Muratet (6791678)   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy